WHO ICTRP trial
Effect of Tranilast on restenosis of Arteriovenous Fistulas for Hemodialysis.
JPRN-UMIN000004251 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000004251 |
|---|---|
| Public title | Effect of Tranilast on restenosis of Arteriovenous Fistulas for Hemodialysis. |
| Scientific title | Effect of Tranilast on restenosis of Arteriovenous Fistulas for Hemodialysis. - Effect of Tranilast on restenosis of Arteriovenous Fistulas for Hemodialysis. |
| Primary sponsor | Department of Nephrology and Hypertension, St. Marianna University School of Medicine |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | hemodialysis patients |
| Interventions | It is the crossover trials which is receving tranilast for one year and non-medication for one year. It is the crossover trials which is receving tranilast for one year and non-medication for one year. |
| Registration date | Jan 12, 2010 |
| Target size | 60 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: